Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.

Yang XiPan YuefenWu WeiQi QuanZhuang JingXu JiaminShu-Wen Han

Published in: Journal of translational medicine (2019)

There are many differences in prognosis, genome, drug targets, gut microbiome, and microbial metabolome in different colorectal cancer sites. These findings may improve our understanding of the role of the CRC sites in personalized and precision medicine.

Keyphrases

microbial community
genome wide
drug induced
adverse drug